CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Developing and commercializing active ingredients from natural sources for healthcare and personal care industries.
Learn More about our ProductsPGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGXTSX Venture
CZO
Change
Volume
Day Range
52 Week Range
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Ceapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Ceapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational Highlights
Nov 29, 2023 | Read More
Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases
Nov 27, 2023 | Read More
Ceapro Inc. Enters into Technical Collaboration with NATEX Prozesstechnologie GmbH and Provides Update on the Scale-Up Project for its Patented Pressurized Gas eXpanded (PGX) Technology
Nov 7, 2023 | Read More
Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results and Provides Corporate Update
Aug 29, 2023 | Read More